Interestingly, IDH, histone H3, and hTERT alterations were rare in ALT+, ATRX-null, and NF1-mutant gliomas [86,90,96,119], while the co-occurrence of TP53 mutations remains unclear [86,90,119]. Here, IDH1 is linked to central nervous system cancer.